#USA #Tel Aviv #Varana Capital #Stämm #SuperMeat

Joint Efforts to Revolutionize Cultivated Meat Production

Stämm and SuperMeat have formed a groundbreaking partnership aimed at accelerating the production of cultivated meat, particularly focusing on chicken. This collaboration is supported by Varana Capital, a mutual investor in both companies, who is offering strategic backing to facilitate their joint objectives.

The Power of Bioreactor Technology

Stämm is renowned for its innovative technology in biopharmaceutical manufacturing, and it is now venturing into the food technology sector. The partnership is primarily focused on deploying Stämm's latest continuous-flow, bubble-free bioreactor technology. This innovative approach promises substantial cost savings and boosts productivity, increasing output by up to 15 times when compared to traditional methods.

SuperMeat has emerged as the perfect pilot partner, having made strides in achieving cost parity in cultivated chicken production, now priced at $11.79 per pound. The company merges unparalleled speed with high yield rates directly from animal cells. Together with Stämm, they aim to optimize the entire production process for cultivated chicken.

Future Prospects of the Partnership

In the upcoming months, both teams will explore how to integrate Stämm's bioprocessor into SuperMeat's existing production workflow. Yuyo Llamazares Vegh, CEO of Stämm, voiced enthusiasm, stating, "We are eager to evaluate the integration of our bioprocessor into SuperMeat’s production processes and unveil the results of our collaboration."

This partnership also extends its goal to enhance the growth, extension, and fusion of muscle fibers into mature muscle tissue, ultimately leading to the efficient creation of whole cuts of meat. Advances in fat cell formation are expected to significantly improve overall product mass, enabling the development of cultivated meat that closely mirrors the structure and taste of traditional meat.

Ido Savir, CEO of SuperMeat, highlighted the complementary nature of their technologies, explaining, "This partnership illustrates the potential of combining complementary technologies to drive significant advancements within the cultivated meat sector. Our collaboration strengthens the pathway toward higher quality, attractive cultivated meat products."

Scaling Up for Economic Viability

The two companies are committed to developing models for scaling their processes along with an economic feasibility study of their production centers. Experimental measurements will demonstrate Stämm's potential to lower product costs through enhanced cultivation media efficiency in biomass production.

According to a recent report by BCG and Blue Horizon, the alternative protein market is projected to reach $290 billion by 2035, marking an enormous business opportunity for innovative companies like Stämm and SuperMeat.

Ezra Gardner, co-founder and Director of Informatics at Varana Capital, emphasizes Israel's unique position in this field, stating, "The exceptional entrepreneurial spirit and technological expertise found in Israel makes it an ideal destination for investments aimed at advancing the alternative protein production revolution, especially as we merge Stämm's biofabrication innovations with SuperMeat’s ingenuity."

Companies Overview

Stämm specializes in continuous bioreactor technology to transform biofabrication, thus enhancing productivity and scalability for partners worldwide.

SuperMeat is a forerunner in the cultivated chicken sector, dedicated to transforming the food system through scalable, sustainable, and accessible alternative proteins.

Varana Capital, based in Denver and Tel Aviv, actively invests in visionary leaders, driving global impact through strategic partnerships across the public and private sectors. Both Stämm and SuperMeat lean into innovation to deliver promising solutions for meat production as a response to growing sustainability concerns.

For more details, visit: Stämm and SuperMeat.